Krilogy Financial Portfolio holdings
Krilogy is a wealth management firm that has added a tax practice, a law practice and a retirement plan group alongside its investment services. Krilogy Tax came in 2017, Krilogy Law in 2020, and (K) Plans, which works only with company retirement plans, followed after that. Kent Skornia is its president and chief executive. Its core investment philosophy is long-term, and it serves high and ultra-high net worth individuals and families, retirement plans, charities, foundations and businesses. Through its Krilogy Portfolio Services division, it also supplies investment management and research to other advisers and their clients.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$110M |
| 2 |
iShares iBonds Dec 2056 Term Treasury ETF
IBGM
|
+$37.8M |
| 3 |
JPMorgan Short Duration Core Plus ETF
JSCP
|
+$30.1M |
| 4 |
iShares iBonds Dec 2046 Term Treasury ETF
IBGC
|
+$20.2M |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$11.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$31.3M |
| 2 |
Dimensional US Core Equity Market ETF
DFAU
|
+$15.2M |
| 3 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$12.6M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$11M |
| 5 |
VanEck Agribusiness ETF
MOO
|
+$9.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.73% |
| 2 | Technology | 12.03% |
| 3 | Industrials | 7.44% |
| 4 | Financials | 4.01% |
| 5 | Healthcare | 3.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Palantir
PLTR
$416B
| $4.74M | 0.13% |
22,656
+3,756
| +20% | +$599K |
2025 Q3
4 quarters
|
|
127
Altria Group
MO
$129B
| $4.71M | 0.13% |
65,764
+643
| +1% | +$44.6K |
2024 Q1
10 quarters
|
|
128
Invesco S&P 500 Equal Weight ETF
RSP
$104B
| $4.68M | 0.13% |
21,937
-2,682
| -11% | -$580K |
2023 Q3
12 quarters
|
|
129
Thermo Fisher Scientific
TMO
$266B
| $4.65M | 0.13% |
7,018
-584
| -8% | -$347K |
2025 Q3
4 quarters
|
|
130
Mastercard
MA
$576B
| $4.61M | 0.13% |
7,747
+1,667
| +27% | +$937K |
2025 Q3
4 quarters
|
|
131
Phillips 66
PSX
$101B
| $4.61M | 0.13% |
16,377
+549
| +3% | +$125K |
2025 Q3
4 quarters
|
|
132
Centene
CNC
$34.9B
| $4.6M | 0.13% |
68,679
+296
| +0.4% | +$19.3K |
2025 Q3
4 quarters
|
|
133
Morgan Stanley
MS
$298B
| $4.54M | 0.12% |
23,907
+1,181
| +5% | +$251K |
2024 Q1
10 quarters
|
|
134
Comfort Systems
FIX
$40.9B
| $4.52M | 0.12% |
2,761
-998
| -27% | -$1.68M |
2025 Q3
4 quarters
|
|
|
135
iShares 20+ Year Treasury Bond ETF
TLT
$48.5B
| $4.45M | 0.12% |
57,066
-380,082
| -87% | -$31.3M |
2016 Q1
42 quarters
|
|
136
Guardant Health
GH
$20.9B
| $4.31M | 0.12% |
26,501
-2,423
| -8% | -$396K |
2026 Q1
2 quarters
|
|
137
Bank of America
BAC
$350B
| $4.31M | 0.12% |
78,959
-5,314
| -6% | -$324K |
2015 Q3
44 quarters
|
|
138
Reading International Class A
RDI
$41.9M
| $4.3M | 0.12% |
2,322,925
-217,763
| -9% | -$371K |
2022 Q4
15 quarters
|
|
139
Oracle
ORCL
$400B
| $4.29M | 0.12% |
31,241
+12,951
| +71% | +$1.83M |
2025 Q1
6 quarters
|
|
140
Vanguard Morningstar Small-Cap ETF
VB
$80.1B
| $4.28M | 0.12% |
14,866
-1,214
| -8% | -$362K |
2025 Q3
4 quarters
|
|
141
AbbVie
ABBV
$521B
| $4.27M | 0.12% |
15,194
-638
| -4% | -$164K |
2023 Q4
11 quarters
|
|
142
Intel
INTC
$332B
| $4.23M | 0.12% |
41,744
+8,354
| +25% | +$852K |
2024 Q4
7 quarters
|
|
143
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
| $4.15M | 0.11% |
17,684
-342
| -2% | -$83.5K |
2025 Q3
4 quarters
|
|
144
Applied Materials
AMAT
$314B
| $4.09M | 0.11% |
8,220
+592
| +8% | +$301K |
2024 Q3
8 quarters
|
|
145
Bristol-Myers Squibb
BMY
$129B
| $4.06M | 0.11% |
70,593
-1,822
| -3% | -$115K |
2024 Q4
7 quarters
|
|
146
UnitedHealth
UNH
$361B
| $4M | 0.11% |
10,572
+521
| +5% | +$210K |
2025 Q3
4 quarters
|
|
147
U.S. Core Equity 1 Portfolio ETF Class Shares
DCOR
$3.57B
| $4M | 0.11% |
47,336
+31,666
| +202% | +$2.65M |
2025 Q3
4 quarters
|
|
148
Caterpillar
CAT
$275B
| $3.98M | 0.11% |
4,980
+408
| +9% | +$346K |
2025 Q3
4 quarters
|
|
149
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$42.5B
| $3.96M | 0.11% |
65,056
-6,356
| -9% | -$379K |
2024 Q1
10 quarters
|
|
150
Atlassian
TEAM
$38.6B
| $3.94M | 0.11% |
18,951
+658
| +4% | +$94.8K |
2025 Q3
4 quarters
|
|
Similar funds
Krilogy Financial's Q3 2026 Portfolio in Review
As of Q3 2026, Krilogy Financial held 1,198 positions worth $3.66B, up 8.3% from $3.38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Krilogy Financial deployed $234M of net new capital in Q3 2026, opening 127 new positions and adding to 525 existing holdings. Its largest new stake was iShares iBonds Dec 2056 Term Treasury ETF: 1,586,275 shares worth $35.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 62% of assets, down from 65% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $31.3M trimmed.
- Krilogy Financial's largest Q3 2026 buy was iShares iBonds Dec 2056 Term Treasury ETF: 1,586,275 shares worth $35.8M.
- Krilogy Financial added most to SpaceX in Q3 2026, an estimated $110M increase.
- Krilogy Financial's biggest Q3 2026 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $31.3M.
- Krilogy Financial fully exited VanEck Agribusiness ETF in Q3 2026, selling an estimated $9.32M.
- Krilogy Financial's ten largest holdings make up 26% of its $3.66B portfolio in Q3 2026.
- Krilogy Financial opened 127 new positions and closed 115 in Q3 2026.
- Krilogy Financial's portfolio value rose 8.3% quarter-over-quarter to $3.66B.
Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.